Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

22 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Femhrt Articles

New Warner Chilcott posts 1st-qtr loss

11 July 2005

Warner Chilcott's low-dose femhrt approved

24 January 2005

UPDATE: Ireland's Warner Chillcott mulls L1.7 billion offer from private equity group

27 September 2004

Warner Chilcott beats expectations

16 August 2004

Galen sees 2nd-qtr 2004 EPS rocket 84%

24 May 2004

Galen reports 105% leap in 1st-qtr sales

16 February 2004

Sales strong at Galen on acquisition spree, organic growth now sought

17 November 2003

Barr Labs and Galen in oral contraceptives licensing deal

22 September 2003

Sales rise on acquisitions at Galen; underlying growth solid in second quarter

18 August 2003

Stock Commentary - Europe

18 August 2003

Galen completes Pfizer product acquisitions

28 April 2003

Galen seeking to buy Pfizer drugs for $359M

10 March 2003

Pfizer and Warner-Lambert merger creates industry's largest R&D budget

10 February 2000

Warner-Lambert's Lipitor And Rezulin Will Fuel Growth

9 September 1998

W-L To Stay Independent As Product Line Improves

30 April 1998

W-L To Stay Independent As Product Line Improves

24 April 1998

Showing 1-16 of 16 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Is failure to adopt business process management putting the pharma industry at risk?
  • New Zealand declines Alexion's funding application for Solaris
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
  • Elan makes "transformational" acquisitions and a divestment
  • Is failure to adopt business process management putting the pharma industry at risk?
  • New Zealand declines Alexion's funding application for Solaris
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
  • Elan makes "transformational" acquisitions and a divestment

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS